Innovation1 Biotech Inc. financial data

Location
179 Rte 46 W, Suite 15 #147, Rockaway, NJ
Fiscal year end
August 31
Latest financial report
10-Q - Q1 2024 - May 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.28 % +52%
Debt-to-equity -148 % -180%
Return On Equity 247 %
Return On Assets -520 % -332%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.5M shares
Common Stock, Shares, Outstanding 22.5M shares +12.2%
Entity Public Float 6.24M USD 0%
Common Stock, Value, Issued 22.5K USD +12.2%
Weighted Average Number of Shares Outstanding, Basic 22.5M shares +12.2%
Weighted Average Number of Shares Outstanding, Diluted 22.5M shares +12.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
Research and Development Expense 0 USD -100%
General and Administrative Expense 110K USD -81.2%
Operating Income (Loss) -2.43M USD -39.4%
Nonoperating Income (Expense) 139K USD
Net Income (Loss) Attributable to Parent -5.3M USD +86.8%
Earnings Per Share, Basic -0.02 USD/shares +95%
Earnings Per Share, Diluted -0.02 USD/shares +95%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 108K USD
Assets, Current 119K USD -16.4%
Property, Plant and Equipment, Net 1.05K USD -50%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 122K USD -96.8%
Accounts Payable, Current 355K USD +11.6%
Accrued Liabilities, Current 179K USD -67.9%
Liabilities, Current 2.9M USD +24.4%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 3.46M USD +46.7%
Retained Earnings (Accumulated Deficit) -59.6M USD -11.5%
Stockholders' Equity Attributable to Parent -3.34M USD -326%
Liabilities and Equity 122K USD -96.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 151K USD -22.7%
Net Cash Provided by (Used in) Financing Activities 107K USD +114%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 22.5M shares +12.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 108K USD +105%
Interest Paid, Excluding Capitalized Interest, Operating Activities 133K USD +1002%
Deferred Tax Assets, Valuation Allowance 14.4M USD +19.6%
Deferred Tax Assets, Gross 10.8M USD +9.44%
Operating Lease, Liability 0 USD -100%
Depreciation 1.05K USD 0%
Operating Lease, Liability, Current 0 USD -100%
Additional Paid in Capital 56.2M USD +2.46%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 49.1K USD -267%